Impact of education family support behaviors on adherence to the drug patients with Myocardial Infarction

Background and Aim: Failure to follow the drug is common in patients with myocardial infarction. However, it has been reported in various studies that family support can improve adherence to drug in chronic diseases. The purpose of this study was to investigation the impact of education of family support behaviors on adherence to the drug in patients with Myocardial Infarction. Materials and Methods: This controlled clinical trial study was performed on 70 patients with myocardial infarction, which had criteria for entering the study. Patients were randomly divided into intervention and control groups and demographic information and adherence to the drug was completed questionnaire for two groups. Individuals who received inadequate the drug follow-up based on this questionnaire were completed their family support questionnaire. In order to intervene, in the form of at least three educational sessions, based on the needs assessment of the two previous questionnaires, training was provided to the key member of the intervention group family and three months after the intervention, the two drug and family support questionnaires were re-completed for the two groups. Finally, the data was entered into SPSS software (version 16). Descriptive statistics including frequency, mean, standard deviation for description and description of data and analytical statistics including: Chi-square, paired T-test and independent T-test were used for data analysis. The significance level was considered as (P <0.05.) Results: The mean score of family supportive behaviors and adherence to the drug in the intervention group was significantly higher than the control group after the intervention (P <0.001). Also, the mean of changes in drug follow-up (P <0.001) and family support (P <0.001) after intervention in the intervention group were significantly higher than the control group. Conclusion: The teaching of family supportive behaviors can improve the adherence to the drug in patients with myocardial infarction.